• 1
    Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 1098104.
  • 2
    Keenan GF, Schaible TF, Boscia JA. Reply to Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001; 344: 1099100.
  • 3
    Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, Webb GR, et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002; 99: 342731.
  • 4
    Wolfs TGAM, Buurman WA, van Schadewijk A, de Vries B, Daemen MARC, Hiemstra PS, et al. In vivo expression of toll like receptor 2 and 4 by renal epithelial cells: IFNgamma and TNF mediated up-regulation during inflammation. J Immunol 2002; 168: 128693.
  • 5
    Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2000; 165: 57807.
  • 6
    Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163: 39207.
  • 7
    Netea MG, de Graaf C, Vonk A, Verschueren I, Van der Meer JWM, Kullberg BJ. The role of toll-like receptors in the defense against disseminated candidiasis. J Infect Dis 2002; 185: 14839.
  • 8
    Wang JE, Warris A, Ellingsen EA, Jorgensen PF, Flo TH, Espevik T, et al. Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun 2001; 69: 24026.
  • 9
    Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 56172.
  • 10
    Senaldi G, Yin S. Corynebacterium parvum and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knock-out mice and by treatment with soluble TNF-RI. J Immunol 1996; 157: 50226.
  • 11
    Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Role of T cells, TNF and IFNgamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro-Salmonella vaccines. Microb Pathog 1992; 13: 47791.
  • 12
    Kullberg BJ, Van't Wout JW, Hoogstraten C, Van Furth R. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 1993; 168: 43643.
  • 13
    Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002; 32: 97105.
  • 14
    Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186: 15225.
  • 15
    Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162: 102832.